drugset / Trial / NCT07538648
A Phase II Clinical Study Evaluating the Effectiveness of Injectable NC527-X in Intraoperative Imaging for Patients With Solid Tumors
NaSingle-groupOpen-labelDiagnostic
Summary
Evaluate the initial dose-effect and time-effect relationship of the injection product NC527-X
Timeline
- Start
- 2025-12-24
- Primary completion
- 2026-12-31
- Completion
- 2027-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | NC527-X | Unknown | 0.005 mg/kg | — |
| Subject | NC527-X | Unknown | 0.01 mg/kg | — |
| Subject | NC527-X | Unknown | 0.02 mg/kg | — |
| Subject | NC527-X | Unknown | 0.04 mg/kg | — |